Dao K, Shechtman S, Weber-Schoendorfer C, Diav-Citrin O, Murad RH, Berlin M, et al
Incretin-based therapies, specifically agonists of glucagon-like peptide-1 receptors (GLP-1 RAs) and glucose-dependent insulinotropic polypeptide (GIP) receptors, have demonstrated benefits for regulating appetite, improving glucose homeostasis, and reducing cardiovascular risk (2, 3)
The efficacy and individual outcomes may vary, and its always recommended to consult with a healthcare professional before starting any new supplementation or treatment regimen
Participants with autoimmune disease, psychiatric disorder, infected ulcer, osteomyelitis, ischemia, and/or contraindications to treatment methods were excluded
This means that there is no risk of overdosing when you get a vitamin B12 shot
Kholodenko et al